Zishiri E, Williams S, Cronin EM, et al. Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator. Circ Arrhythm Electrophysiol. 2013;6:117-128. Abstract
Solomon SD, Zelenkofske S, McMurray JJ, et al; Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med. 2005;352:2581-2588. Abstract
Halkin A, Singh M, Nikolsky E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol. 2005;45:1397-1405. Abstract
Hohnloser SH, Kuck KH, Dorian P, et al; DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481-2488. Abstract
MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001-2007. Abstract
Saltzberg MT, Szymkiewicz S, Bianco NR. Characteristics and outcomes of peripartum versus nonperipartum cardiomyopathy in women using a wearable cardiac defibrillator. J Card Fail. 2012;18 :21-27. Abstract
Kutyifa V, Goldenberg I, Zareba W, et al. Results from the prospective registry of patients using the wearable defibrillator (WEARIT-II registry). Paper presented as a late breaking clinical trial at: European Society of Cardiology (ESC) Congress 2014; August 30, 2014; Barcelona, Spain.
Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J. 2007;154:260-266. Abstract

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Moderator(s)

Rahul N. Doshi, MD

Assistant Professor of Medicine, University of California at Irvine; Director, Electrophysiology, University of California at Irvine Medical Center, St. Jude Medical Center, Irvine, California

Disclosures

Disclosure: Rahul N. Doshi, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: St. Jude Medical
Served as a speaker or a member of a speakers bureau for: Boston Scientific; St. Jude Medical

Dr Doshi does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Doshi does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Panelist(s)

James L. Januzzi, MD

Hutter family Professor of Medicine, Harvard Medical School; Roman W. DeSanctis Endowed Clinical Scholar, Massachusetts General Hospital, Boston, Massachusetts

Disclosures

Disclosure: James L. Januzzi, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Critical Diagnostics; Roche; sphingotec GmbH
Received grants for clinical research from: Siemens AG; Singulex; Thermo Fisher Scientific Inc.

Dr Januzzi does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Januzzi does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Sunil V. Rao, MD

Associate Professor of Medicine, Duke University Medical Center; Director, Cardiac Catheterization Lab, Durham VA Medical Center, Durham, North Carolina

Disclosures

Disclosure: Sunil V. Rao, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Medtronic, Inc.; Terumo Medical Corporation; The Medicines Company
Served as a speaker or a member of a speaker’s bureau for: Medtronic, Inc.
Received grants for clinical research from: Bellerophon Therapeutics

Dr Rao does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Rao does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Ulrika Birgersdotter-Green, MD

Professor of Medicine; Director, Pacemaker and ICD Services, University of California, San Diego, California

Disclosures

Disclosure: Ulrika Birgersdotter-Green, MD, has disclosed the following relevant financial relationships:
Served as an advisor or a member of a speakers bureau for: Boston Scientific; Medtronic, Inc.; St. Jude Medical

Dr Birgersdotter-Green does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Birgersdotter-Green does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor(s)

George Boutsalis, PhD

Scientific Director, Medscape, LLC

Disclosures

Disclosure: George Boutsalis, PhD, has disclosed no relevant financial relationships.

Ronald K. Miller, PhD

Scientific Director, Medscape, LLC

Disclosures

Disclosure: Ronald K. Miller, PhD, has disclosed no relevant financial relationships.

CME Reviewer(s)

Amy Bernard, MS, BSN, RN-BC

Lead Nurse Planner, Medscape, LLC

Disclosures

Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationships.

CME

Remote Patient Management: Strategies to Protect the Patient After an MI

Authors: Rahul N. Doshi, MD; James L. Januzzi, MD; Sunil V. Rao, MD; Ulrika Birgersdotter-Green, MD
CME Released: 3/24/2015; Reviewed and Renewed: 7/5/2016
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 7/5/2017

Start Activity

Target Audience and Goal Statement

This activity is intended for electrophysiologists, interventional cardiologists, and clinical cardiologists.

The goal of this activity is to inform physicians on management strategies for patients at risk for sudden cardiac death when an ICD is not an option.

Upon completion of this activity, participants will be able to:

Discuss how to better manage and protect patients in the 90-day period post-MI
Review actionable data to consider in that period based on patient characteristics and how to implement into clinical practice

Disclosures

Moderator(s)

Rahul N. Doshi, MD

Assistant Professor of Medicine, University of California at Irvine; Director, Electrophysiology, University of California at Irvine Medical Center, St. Jude Medical Center, Irvine, California

Disclosures

Disclosure: Rahul N. Doshi, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: St. Jude Medical
Served as a speaker or a member of a speakers bureau for: Boston Scientific; St. Jude Medical

Dr Doshi does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Doshi does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Panelist(s)

James L. Januzzi, MD

Hutter family Professor of Medicine, Harvard Medical School; Roman W. DeSanctis Endowed Clinical Scholar, Massachusetts General Hospital, Boston, Massachusetts

Disclosures

Disclosure: James L. Januzzi, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Critical Diagnostics; Roche; sphingotec GmbH
Received grants for clinical research from: Siemens AG; Singulex; Thermo Fisher Scientific Inc.

Dr Januzzi does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Januzzi does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Sunil V. Rao, MD

Associate Professor of Medicine, Duke University Medical Center; Director, Cardiac Catheterization Lab, Durham VA Medical Center, Durham, North Carolina

Disclosures

Disclosure: Sunil V. Rao, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Medtronic, Inc.; Terumo Medical Corporation; The Medicines Company
Served as a speaker or a member of a speaker’s bureau for: Medtronic, Inc.
Received grants for clinical research from: Bellerophon Therapeutics

Dr Rao does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Rao does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Ulrika Birgersdotter-Green, MD

Professor of Medicine; Director, Pacemaker and ICD Services, University of California, San Diego, California

Disclosures

Disclosure: Ulrika Birgersdotter-Green, MD, has disclosed the following relevant financial relationships:
Served as an advisor or a member of a speakers bureau for: Boston Scientific; Medtronic, Inc.; St. Jude Medical

Dr Birgersdotter-Green does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Birgersdotter-Green does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor(s)

George Boutsalis, PhD

Scientific Director, Medscape, LLC

Disclosures

Disclosure: George Boutsalis, PhD, has disclosed no relevant financial relationships.

Ronald K. Miller, PhD

Scientific Director, Medscape, LLC

Disclosures

Disclosure: Ronald K. Miller, PhD, has disclosed no relevant financial relationships.

CME Reviewer(s)

Amy Bernard, MS, BSN, RN-BC

Lead Nurse Planner, Medscape, LLC

Disclosures

Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationships.

Accreditation Statements

For Physicians

Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

Strategies to Reduce the Risk for Sudden Cardiac Death

From Medscape Education Cardiology

CME

Remote Patient Management: Strategies to Protect the Patient After an MI

Authors: Rahul N. Doshi, MD; James L. Januzzi, MD; Sunil V. Rao, MD; Ulrika Birgersdotter-Green, MDFaculty and Disclosures

THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME Released: 3/24/2015; Reviewed and Renewed: 7/5/2016

Valid for credit through: 7/5/2017

processing....

This feature requires the newest version of Flash. You can download it here.

CME Information Download Slides

Print
Like Tweet

Disclaimer

The educational activity presented above may involve simulated case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient is intended or should be inferred.

The material presented here does not necessarily reflect the views of Medscape, LLC, or companies that support educational programming on medscape.org. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

References

Faculty and Disclosures

Moderator(s)

Rahul N. Doshi, MD

Panelist(s)

James L. Januzzi, MD

Sunil V. Rao, MD

Ulrika Birgersdotter-Green, MD

Editor(s)

George Boutsalis, PhD

Ronald K. Miller, PhD

CME Reviewer(s)

Amy Bernard, MS, BSN, RN-BC

CME

Remote Patient Management: Strategies to Protect the Patient After an MI

Target Audience and Goal Statement

Disclosures

Moderator(s)

Rahul N. Doshi, MD

Panelist(s)

James L. Januzzi, MD

Sunil V. Rao, MD

Ulrika Birgersdotter-Green, MD

Editor(s)

George Boutsalis, PhD

Ronald K. Miller, PhD

CME Reviewer(s)

Amy Bernard, MS, BSN, RN-BC

Accreditation Statements

For Physicians

Instructions for Participation and Credit

Remote Patient Management: Strategies to Protect the Patient After an MI